Spectrum of movement disorders in neuroferritinopathy

Movement Disorders : Official Journal of the Movement Disorder Society
Douglas E CromptonJohn Burn

Abstract

Neuroferritinopathy is a recently recognized, dominantly inherited movement disorder caused by a mutation of the ferritin light chain gene. We present video case reports of 4 individuals with neuroferritinopathy chosen to illustrate how this disorder can present and subsequently progress clinically. The clinical phenotype of this disorder is highly variable with symptoms beginning in the third to sixth decades. Chorea, dystonia, or an akinetic-rigid syndrome can predominate in different individuals. Neuroferritinopathy is not restricted to the UK and it has been described in apparently sporadic cases. The diagnosis should therefore be considered in patients with a wide variety of different movement disorders. Characteristic neuroimaging assists in identifying affected individuals.

References

Jun 1, 1990·American Journal of Medical Genetics·K G KupkeU Müller
Oct 1, 1987·American Journal of Medical Genetics·J M VanceE W Massey
May 10, 2000·Neurology·S B BressmanN J Risch
May 29, 2000·The New England Journal of Medicine·C B LückingUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
May 29, 2000·Brain : a Journal of Neurology·J TassinA Brice
Jun 26, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·A J WillsA R J Curtis
Aug 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·J M S Pearce
Jan 3, 2003·The New England Journal of Medicine·Susan J HayflickJane Gitschier
Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Thomas GasserRichard H Myers
May 15, 2003·Journal of Medical Genetics·P F ChinneryJ Burn

❮ Previous
Next ❯

Citations

Feb 3, 2011·Current Neurology and Neuroscience Reports·Allison Gregory, Susan J Hayflick
Aug 26, 2006·Nature Clinical Practice. Neurology·Oksana Suchowersky, Joy Muthipeedika
Sep 13, 2007·The Neurologist·Ramon L RodriguezMichael S Okun
Aug 3, 2011·Neurology Research International·Emiko Ohta, Yoshihisa Takiyama
Jul 15, 2009·Rinshō shinkeigaku = Clinical neurology·Emiko OhtaZenji Shiozawa
Jul 24, 2012·Parkinsonism & Related Disorders·Alexander LehnGeorge Mellick
May 10, 2011·Parkinsonism & Related Disorders·Andrzej FriedmanJolanta Galazka-Friedman
Sep 8, 2010·Revue neurologique·A E Elia, A Albanese
Sep 18, 2007·Progress in Neurobiology·Ya Ke, Zhong Ming Qian
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Fabienne Ory-MagneOlivier Rascol
Mar 17, 2015·Neurobiology of Disease·Sonia Levi, Ermanna Rovida
May 16, 2014·Journal of the Neurological Sciences·Katsuya NishidaMasaki Takao
Jan 27, 2015·Current Neurology and Neuroscience Reports·Andreas Hermann, Ruth H Walker
Oct 5, 2013·Continuum : Lifelong Learning in Neurology·Ruth H Walker
Jul 18, 2020·Journal of Huntington's Disease·Jaslovleen KaurMohd Faruq
Apr 6, 2011·Current Neurology and Neuroscience Reports·Ruth H Walker
Jan 14, 2021·Cellular and Molecular Life Sciences : CMLS·Anna CozziSonia Levi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.